Leading source of Financial News, Investor Forums, CEO Interviews, Financial Columnists, Stock Information

Add to MyProactive

Acasti Pharma Inc - Acasti Phamra Inc remains a Speculative Buy following a regulatory decision to broadening the label for rival Amrian’s Vascepa heart drug, according to Makie Research

Acasti Pharma remains Speculative Buy following FDA win for rival's heart drug: Mackie

1 day, 7 hours ago

Dyadic at the Nasdaq

Noble Research repeats Outperform rating and $9 target on Dyadic following third quarter results

1 day, 8 hours ago

pot leaves

Buds & Duds: Cannabis stocks stabilize following a rocky week of disappointing earnings; Helix TCS bucks the trend by turning $1.5 million profit

1 day, 8 hours ago

Agile Therapeutics - Agile Therapeutics Inc announces the US Food and Drug Administration has extended the goal date for its review of the New Drug Application for its investigational prescription contraceptive patch Twirla

Agile Therapeutics wins FDA review extension of NDA for Twirla contraceptive

2 days, 3 hours ago

Exactus, Inc -

Exactus 2019 harvest beating expectations thanks to better-than-anticipated growing conditions

2 days, 3 hours ago

CytoDyn -

CytoDyn appoints finance veteran Craig S Eastwood as chief finance officer

2 days, 12 hours ago

Plants sprouting from increasingly tall stacks of coins, one plant sprouting from a jar of coins

Dyadic International flexes growing R&D revenue, robust cash position in 3Q results

3 days, 3 hours ago

Acasti Pharma Inc -

Acasti Pharma eyeing 2021 as US launch date for lead drug CaPre

3 days, 7 hours ago

TransCanna -

Buds & Duds: Cannabis stocks sink as Cronos, Tilray feel the effects of oversupply in Canada

3 days, 8 hours ago

VolitionRx - VolitionRx boosts it balance sheet in third quarter, strengthens its product pipeline

VolitionRx boosts its balance sheet in third quarter, strengthens its product pipeline

3 days, 10 hours ago

$100 bills

Matinas BioPharma Holdings flashes strong cash on hand in 3Q results, issues drug pipeline update

3 days, 10 hours ago

Cannabis on a globe

ICC International Cannabis inks termination deal with Wayland Group to reverse international asset purchase

3 days, 11 hours ago

Mereo BioPharma Group PLC - Mereo BioPharma CEO confident as it moves forward with pivotal Setrusumab study

Mereo BioPharma CEO confident as it moves forward with pivotal Setrusumab study

3 days, 11 hours ago

VolitionRx - VolitionRx records first revenues from research kits and strengthens balance sheet in third quarter

VolitionRx records first revenues from research kits and strengthens balance sheet in third quarter

3 days, 12 hours ago

CytoDyn - CytoDyn wins IRB approval to give leronlimab to triple-negative breast cancer patients on compassionate grounds

CytoDyn wins IRB approval to give leronlimab to triple-negative breast cancer patients on compassionate grounds

3 days, 12 hours ago

MRI showing gliblastoma

Humanigen to present abstracts highlighting its glioblastoma treatments at industry conference

4 days, 3 hours ago

Weekend Unlimited Inc. -

Buds & Duds: Cannabis stocks a mixed bag as big names report results; Weekend Unlimited rises on hemp license

4 days, 8 hours ago

cannabis bud and flower

Namaste subsidiary CannMart signs new supply deal with governments of Ontario and Saskatchewan

4 days, 9 hours ago

Parallax Health Sciences - Parallax Health Sciences Inc subsidiary Parallax Behavioral Health Inc enters into vertical market licenses in financial technology, human resource, lifestyle and healthcare fields

Parallax Health Sciences subsidiary achieves vertical market integration

4 days, 9 hours ago

Patented stamp

Zynerba Pharmaceuticals wins US patent for treatment of Fragile X syndrome with its Zygel CBD gel

4 days, 10 hours ago